BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: NF-κB interacting lncRNA (NKILA)

...Cancer INDICATION: Breast cancer Studies in cell culture, patient samples and mice suggest NKILA could help...
...cancer cell lines, wild-type NKILA increased apoptosis and decreased invasiveness compared with an inactive mutant NKILA...
...steps include identifying the NKILA domain responsible for its anti-metastatic activity. TARGET/MARKER/PATHWAY: NF-κB interacting lncRNA (NKILA...
Items per page:
1 - 1 of 1